Short Interest in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Rises By 6.0%

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) was the target of a significant growth in short interest in October. As of October 15th, there was short interest totalling 1,230,000 shares, a growth of 6.0% from the September 30th total of 1,160,000 shares. Based on an average daily trading volume, of 341,700 shares, the days-to-cover ratio is presently 3.6 days. Approximately 2.2% of the shares of the stock are sold short.

Institutional Trading of Aveanna Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Littlejohn & Co. LLC lifted its stake in Aveanna Healthcare by 7.4% during the first quarter. Littlejohn & Co. LLC now owns 8,377,258 shares of the company’s stock worth $20,859,000 after purchasing an additional 578,488 shares in the last quarter. Vanguard Group Inc. lifted its stake in Aveanna Healthcare by 1.8% during the 1st quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock worth $6,402,000 after acquiring an additional 44,970 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in Aveanna Healthcare by 155.8% during the 2nd quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock valued at $438,000 after acquiring an additional 96,600 shares during the period. Bank of New York Mellon Corp grew its position in Aveanna Healthcare by 6.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock valued at $413,000 after acquiring an additional 9,243 shares in the last quarter. Finally, Acadian Asset Management LLC increased its stake in Aveanna Healthcare by 176.6% during the second quarter. Acadian Asset Management LLC now owns 81,275 shares of the company’s stock worth $222,000 after purchasing an additional 51,890 shares during the period. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have recently issued reports on AVAH. Royal Bank of Canada lifted their target price on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the company a “sector perform” rating in a research report on Friday, August 9th. UBS Group upped their target price on shares of Aveanna Healthcare from $1.70 to $2.80 and gave the stock a “sell” rating in a report on Friday, August 9th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the stock a “buy” rating in a research report on Friday, August 9th.

Aveanna Healthcare Stock Down 4.3 %

Shares of AVAH traded down $0.21 during midday trading on Thursday, reaching $4.70. The company had a trading volume of 123,812 shares, compared to its average volume of 188,167. The firm has a 50 day simple moving average of $5.21 and a 200-day simple moving average of $3.80. The stock has a market cap of $908.16 million, a PE ratio of -7.44 and a beta of 2.12. Aveanna Healthcare has a 1-year low of $1.34 and a 1-year high of $5.95.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.03. The business had revenue of $504.96 million during the quarter, compared to analysts’ expectations of $494.02 million. As a group, sell-side analysts anticipate that Aveanna Healthcare will post -0.09 earnings per share for the current fiscal year.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.